Can Trazodone Be Taken with Ketamine Infusions?
Yes, trazodone can be taken concurrently with ketamine infusion therapy, and there is no contraindication to this combination. In fact, historical evidence suggests trazodone may even help mitigate certain ketamine-related side effects.
Evidence Supporting Concurrent Use
No Drug Interaction Contraindication
The FDA drug label for trazodone 1 does not list ketamine as a contraindicated medication or as having clinically important interactions. The label specifically warns against:
- MAOIs (absolute contraindication)
- Other serotonergic drugs (serotonin syndrome risk)
- CNS depressants (additive sedation)
- QT-prolonging drugs (cardiac arrhythmia risk)
- Strong CYP3A4 inhibitors/inducers
Ketamine does not fall into any of these problematic categories.
Historical Clinical Use
Research from 1977 2 actually studied trazodone specifically for managing ketamine anesthesia recovery reactions. The study found trazodone effective in reducing agitation and making the ketamine experience more tolerable, without the hypnotic complications of benzodiazepines. While this was in an anesthetic context, it demonstrates no dangerous interaction between these medications.
Current Clinical Practice Context
Recent VA/DoD guidelines 3 recommend ketamine infusions for treatment-resistant depression (TRD) when at least 2 adequate antidepressant trials have failed. These guidelines note that ketamine can be used "as monotherapy or in conjunction with an antidepressant" 3. Trazodone, while often used off-label for insomnia 4, is an antidepressant medication, and the guidelines support combining ketamine with ongoing antidepressant therapy.
Important Clinical Considerations
Monitor for Additive CNS Effects
Both medications have CNS depressant properties:
- Trazodone causes sedation and can impair psychomotor performance 1
- Ketamine produces dissociative effects and altered consciousness 5
Practical approach: Patients should be counseled about potentially increased drowsiness or sedation, particularly on infusion days. Avoid driving or operating machinery for 24 hours post-infusion.
Cardiovascular Monitoring
- Trazodone can cause orthostatic hypotension and QT prolongation 1
- Ketamine typically increases heart rate and blood pressure through sympathetic stimulation 6, 7
These effects are generally opposing rather than additive. However, patients with preexisting cardiac disease require closer monitoring, as trazodone carries warnings about cardiac arrhythmias 1.
Timing Considerations
For patients using trazodone primarily for sleep:
- Continue the usual nighttime dose
- No need to hold trazodone on infusion days
- The sedating effects may actually help with post-infusion rest
When to Exercise Caution
Avoid or use extreme caution if:
- Patient has known QT prolongation (both drugs can prolong QT interval)
- Patient is on multiple other CNS depressants (alcohol, benzodiazepines, opioids)
- Patient has severe cardiac disease with arrhythmia history
- Patient is taking strong CYP3A4 inhibitors with trazodone (increases trazodone levels) 1
Bottom Line Algorithm
- Review medication list: Ensure no MAOIs or multiple QT-prolonging drugs
- Assess cardiac history: If significant arrhythmia history, consider EKG
- Continue trazodone: No need to discontinue for ketamine infusions
- Counsel patient: Expect possible increased sedation on infusion days
- Monitor vital signs: Standard ketamine infusion monitoring protocols apply
- Follow-up: Assess for any unusual sedation or cardiovascular symptoms
The combination is generally safe and commonly encountered in clinical practice, as many patients receiving ketamine for TRD are already on multiple psychotropic medications including trazodone for sleep disturbances.